A detailed history of Stiles Financial Services Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stiles Financial Services Inc holds 24,747 shares of BMY stock, worth $1.43 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
24,747
Previous 24,525 0.91%
Holding current value
$1.43 Million
Previous $1.02 Million 25.74%
% of portfolio
0.45%
Previous 0.39%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$39.66 - $51.75 $8,804 - $11,488
222 Added 0.91%
24,747 $1.28 Million
Q2 2024

Aug 01, 2024

BUY
$40.25 - $52.99 $72,812 - $95,858
1,809 Added 7.96%
24,525 $1.02 Million
Q1 2024

Apr 30, 2024

BUY
$47.98 - $54.4 $396,650 - $449,724
8,267 Added 57.22%
22,716 $1.23 Million
Q4 2023

Jan 26, 2024

BUY
$48.48 - $57.85 $242,933 - $289,886
5,011 Added 53.09%
14,449 $741,000
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $170,833 - $191,018
2,951 Added 45.49%
9,438 $547,000
Q2 2023

Jul 21, 2023

BUY
$63.71 - $70.74 $71,928 - $79,865
1,129 Added 21.07%
6,487 $414,000
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $11,499 - $13,042
175 Added 3.38%
5,358 $371,000
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $1,506 - $1,783
22 Added 0.43%
5,183 $0
Q3 2022

Nov 02, 2022

SELL
$0.13 - $76.84 $15 - $9,297
-121 Reduced 2.29%
5,161 $367,000
Q2 2022

Jul 26, 2022

SELL
$72.62 - $79.98 $78,865 - $86,858
-1,086 Reduced 17.05%
5,282 $407,000
Q1 2022

May 06, 2022

BUY
$61.48 - $73.72 $8,668 - $10,394
141 Added 2.26%
6,368 $465,000
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $333,954 - $389,312
6,227 New
6,227 $388,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stiles Financial Services Inc Portfolio

Follow Stiles Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stiles Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stiles Financial Services Inc with notifications on news.